Form 8-K Purple Innovation, Inc. For: Jul 16
false
--12-31
0001643953
0001643953
2026-07-16
2026-07-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the... (continue reading...)
Form 3 ENERGY CO OF MINAS GERAI For: Jun 11 Filed by: Ferreira Demetrio Alexandre
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 497K Voya INVESTORS TRUST
Summary Prospectus July 17, 2026
Voya Inflation Protected Bond Plus Fund (formerly, Voya Inflation Protected Bond Plus Portfolio)
... (continue reading...)
Form D CBRE UIV IV Master Fund,
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 8-K Cardiff Oncology, Inc. For: Jul 14
0001213037false00012130372026-07-142026-07-14
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 14, 2026
Cardiff Oncology, Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware
More SEC Filings
View Older Stories-
Form 424B5 Cardiff Oncology, Inc.
-
Form 8-K Gevo, Inc. For: Jul 13
-
Form 13F-NT Tompkins Community Bank For: Jun 30
-
Form 8-K Harmony Biosciences Hold For: Jul 16
-
Form 25-NSE XOMA Royalty Corp Filed by: Nasdaq Stock Market LLC
-
Form N-23C3A Palmer Square Opportunis For: Jul 13
-
Form 8-K Sadot Group Inc. For: Jul 15
-
Form 8-K Vivani Medical, Inc. For: Jul 15
-
Form 8-K ETSY INC For: Jul 12
-
Form 6-K CBL International Ltd For: Jul 16
-
Form 6-K Eco Wave Power Global For: Jul 16
-
Form D OurCrowd Access, L.P.
-
Form 13F-HR WORMSER FRERES GESTION For: Jun 30
-
Form 13F-HR Ninety One SA (PTY) Ltd For: Jun 30
-
Form 6-K VODAFONE GROUP PUBLIC For: Jul 16
-
Form 13F-HR WESPAC Advisors SoCal, For: Jun 30
-
Form 13F-HR Ninety One UK Ltd For: Jun 30
-
Form 13F-HR Ninety One North America For: Jun 30
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 8-K New Horizon Aircraft For: Jul 16
-
Form 8-K SharonAI Holdings Inc. For: Jul 16
-
Form 4 Global-E Online Ltd. For: Jul 15 Filed by: Debbi Nir
-
Form 6-K SILICOM LTD. For: Jul 16
-
Form 424B2 Bank of New York Mellon
-
Form 8-K enGene Therapeutics Inc. For: Jul 15
-
Form 8-K Prologis, L.P. For: Jul 16 Filed by: Prologis, Inc.
-
Form 8-K CDT Equity Inc. For: Jul 15
-
Form 3 ENERGY CO OF MINAS GERAI For: Jun 11 Filed by: de Magalhaes Leonardo George
-
Form 8-K TOMI Environmental Solut For: Jul 16
-
Form 8-K/A Edgewise Therapeutics, For: Jul 10
-
Form 8-K Bank7 Corp. For: Jul 16
-
Form 8-K FORUM MARKETS Inc For: Jul 13
-
Form 8-K NextBoat Inc. For: Jul 16
-
Form 13F-HR Sava Infond d.o.o. For: Jun 30
-
Form 6-K VODAFONE GROUP PUBLIC For: Jul 16
-
Form D TCP Classico Alberta
-
Form 8-K Gain Therapeutics, Inc. For: Jul 16
-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form D RADCO Union Terminal
-
Form 6-K TAIWAN SEMICONDUCTOR For: Jun 30
-
Form 8-K ALLSTATE CORP For: Jul 16
-
Form 8-K GIBRALTAR INDUSTRIES, For: Jul 16
-
Form 424B3 JERSEY CENTRAL POWER &
-
Form 6-K Galmed Pharmaceuticals For: Jul 16
-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form 8-K Trilogy Metals Inc. For: Jul 16
-
Form 6-K Brainsway Ltd. For: Jul 16
-
Form 6-K SIFY TECHNOLOGIES LTD For: Jul 16
